TrialChest2022

Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.

Robert P Baughman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.